Browse
Submit Data
Databases
API
Help

Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

9 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcription profiling of human ALL - 35 patients at diagnosis and relapse

ABSTRACT: 35 paired samples from initial diagnosis and first marrow relapse. Genes and pathways differentiating diagnosis and relapse were identified. Potential therapeutic targets were also identified. Experiment Overall Design: 35 patients with samples from initial diagnosis and first marrow relapse.

ORGANISM(S): Homo sapiens

SUBMITTER: Deepa Bhojwani

PROVIDER: E-GEOD-3910 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Publications

Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study.

Bhojwani Deepa D Kang Huining H Moskowitz Naomi P NP Min Dong-Joon DJ Lee Hokyung H Potter Jeffrey W JW Davidson George G Willman Cheryl L CL Borowitz Michael J MJ Belitskaya-Levy Ilana I Hunger Stephen P SP Raetz Elizabeth A EA Carroll William L WL

Blood 20060701 2

Outcome for children with childhood acute lymphoblastic leukemia (ALL) who relapse is poor. To gain insight into the mechanisms of relapse, we analyzed gene-expression profiles in 35 matched diagnosis/relapse pairs as well as 60 uniformly treated children at relapse using the Affymetrix platform. Matched-pair analyses revealed significant differences in the expression of genes involved in cell-cycle regulation, DNA repair, and apoptosis between diagnostic and early-relapse samples. Many of these ...[more]

PMID: 16822902

Similar Datasets

35 patients at diagnosis and relapse

Project description:35 paired samples from initial diagnosis and first marrow relapse. Genes and pathways differentiating diagnosis and relapse were identified. Potential therapeutic targets were also identified. Keywords: paired

2006-03-20 | GSE3910 | GEO

Transcription profiling of human ALL patients, first bone marrow relapse with or without initial diagnosis

Project description:This SuperSeries comprises the following subset Series:; GSE3910: 35 patients at diagnosis and relapse; GSE3911: 60 samples obtained at relapse Experiment Overall Design: Refer to individual Series

2008-06-12 | E-GEOD-3912 | biostudies-arrayexpress

Transcription profiling of human ALL patients with first bone marrow relapse

Project description:Gene expression profiles were analyzed from 60 children with first bone marrow relapse. Genes and pathways differentiating early vs. late relapse were identified. Signatures predicting early response to therapy were also identified. Experiment Overall Design: 60 patients at relapse were analyzed

2008-06-13 | E-GEOD-3911 | biostudies-arrayexpress

Expression data from ALL diagnosis and relapse pediatric acute lymphoblastic leukemia cases

Project description:There is a distinct signature of differentially expressed probes from diagnosis to relapse Gene expression profiles of pediatric patients with B-precursor ALL were compared to at 2 time points, diagnosis and relapse. The overall design was a comparison of gene expression at diagnosis and relapse within individual patients. A subset analysis (comparing diagnosis to relapse expression within individuals), was done for early relapse (less than 36 months) cases only and late relapse (greater than 36 months) cases only.

2011-09-23 | E-GEOD-28460 | biostudies-arrayexpress

Project description:First bone marrow relapse with or without initial diagnosis

| PRJNA94165 | ENA

Comparative genomic hybridization by array of human intracranial childhood ependymomas at diagnosis and relapse

Project description:Goal of the experiment : Recurrence is a frequent phenomenon in intracranial childhood ependymomas. To understand this process, we investigated whether the gene expression profiling of matched ependymomas at diagnosis and at relapse could reveal key molecular events involved in tumor progression. To gain new insight in this process and identify mechanisms associated with recurrence, we compared the CGH profiles of local recurrences with the corresponding initial tumors. Brief description We analyzed 17 tumor samples at diagnosis and a total of 27 paired recurrences. Recurrences analyzed occurred after surgery only in 12 cases, surgery plus chemotherapy only in 9 cases and any treatment plus radiotherapy in 6 cases. We compared the level of CGH profile for each tumor at diagnosis and recurrence relative to normal commercial DNA using Agilent 4x44K Human CGH microarrays.

2011-06-20 | E-TABM-1023 | biostudies-arrayexpress

Homo sapiens

Project description:35 patients at diagnosis and relapse

| PRJNA94333 | ENA

B-ALL relapse analysis

Project description:A comparison of RNA expression profiles from leukemic cells of 8 single B-ALL patients at diagnosis and relapse. For all patients, clonality of the blast cells at diagnosis and relapse was demonstrated to be the same (Germano, G., del Giudice, L., Palatron, S., Giarin, E., Cazzaniga, G., Biondi, A., Basso, G., Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring. Leukemia, 2003). The study protocol was approved by the Research committee of the AIEOP and written informed consent was obtained from all participants before samples were taken. RNA extracted from BM samples was used for microarray analysis. The blast cell infiltration both at diagnosis and relapse was 75% and mononuclear cell were isolated using a Lymphoprep density gradient (1.077 g/ml, Nycomed Pharma, Oslo, Norway). RNA was extracted from blast cells at diagnosis and relapse and both samples were hybridized on an MWG 30K Human Array A (MWG, München) after direct labeling using two different fluorochromes (Cy3 and Cy5) for the respective samples. Keywords = Homo sapiens, B-lymphoblastic leukemia, diagnosis, relapse

2003-06-13 | GSE416 | GEO

Epigenomic Evolution of Diffuse Large B-cell Relapse

Project description:Here we characterize an association between disease progression and DNA methylation in Diffuse Large B cell Lymphoma (DLBCL). By profiling genome-wide DNA methylation at single base-pair resolution in thirteen DLBCL diagnosis-relapse sample pairs, we show DLBCL patients exhibit heterogeneous evolution of tumor methylomes during relapse. We identify differentially methylated regulatory elements and determine a relapse–associated methylation signature converging on key pathways such as transforming growth factor beta (TGF-beta) receptor activity. We also observe decreased intra-tumor methylation heterogeneity from diagnosis to relapsed tumor samples. Relapse-free patients display lower intra-tumor methylation heterogeneity at diagnosis compared to relapsed patients in an independent validation cohort. Furthermore, intra-tumor methylation heterogeneity is predictive of time to relapse. Therefore, we propose that epigenomic heterogeneity may support or drive the relapse phenotype and can be used to predict DLBCL relapse. Using ERRBS, we profiled genome-wide DNA methylation patterns of non-relapse DLBCL tumor samples at diagnosis, relaspe DLBCL patient samples at diagnosis and relaspe.

2015-04-14 | E-GEOD-66329 | biostudies-arrayexpress

7 paired AML Diagnosis vs Relapse patient samples

Project description:MS-based proteomics and phosphoproteomics study based on 7 paired diagnosis-first relapse AML patient samples

2020-06-12 | PXD018359 | Pride